We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
Turnover
16.91%
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+6.95%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$9.81M
(+8%)
Cap. Flow
+$3.88M
Cap. Flow
% of AUM
2.93%
Top 10 Holdings %
Top 10 Hldgs %
31.07%
Holding
141
New
8
Increased
35
Reduced
44
Closed
7
Avg Time Held Equity + Options
2.1
years
Top 10 Avg Time Held Equity + Options
1.1
years
Top 20 Avg Time Held Equity + Options
1.7
years
Avg Time Held Equity only
2.1
years
Top 10 Avg Time Held Equity only
1.1
years
Top 20 Avg Time Held Equity only
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.63M |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.55M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.29M |
| 4 |
KKR & Co
KKR
|
+$941K |
| 5 |
Omega Healthcare
OHI
|
+$856K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sarepta Therapeutics
SRPT
|
+$1.73M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$830K |
| 3 |
Johnson Controls International
JCI
|
+$821K |
| 4 |
Spectra Energy Corp Wi
SE
|
+$571K |
| 5 |
Tapestry
TPR
|
+$462K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.21% |
| 2 | Real Estate | 16.84% |
| 3 | Healthcare | 12.91% |
| 4 | Technology | 12.84% |
| 5 | Financials | 10.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Macy's
M
$6.33B
| $241K | 0.18% |
6,500
-1,500
| -19% | -$54.4K |
2016 Q1
2 quarters
|
|
|
FALC
102
DELISTED
FalconStor Software Inc
FALC
| $231K | 0.17% |
222,100
-80,000
| -26% | -$83.6K |
2013 Q2
13 quarters
|
|
103
VanEck Junior Gold Miners ETF
GDXJ
$8.12B
| $230K | 0.17% |
5,200
| – | – |
2016 Q2
1 quarter
|
|
104
Invesco QQQ Trust
QQQ
$487B
| $228K | 0.17% |
1,920
| – | – |
2015 Q3
4 quarters
|
|
105
FedEx
FDX
$69.9B
| $227K | 0.17% |
+1,300
| New | +$213K |
2016 Q3
0 quarters
|
|
106
Pembina Pipeline
PBA
$28B
| $216K | 0.16% |
7,100
| – | – |
2016 Q1
2 quarters
|
|
107
Kratos Defense & Security Solutions
KTOS
$7.65B
| $189K | 0.14% |
27,500
-10,000
| -27% | -$58.4K |
2013 Q2
13 quarters
|
|
108
Rockwell Medical
RMTI
$32.2M
| $188K | 0.14% |
255
| – | – |
2015 Q4
3 quarters
|
|
109
abrdn Asia-Pacific Income Fund
FAX
$530M
| $182K | 0.14% |
5,917
-33
| -0.6% | -$1.03K |
2013 Q2
13 quarters
|
|
110
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$251M
| – | – |
0
| – | – |
2016 Q3
0 quarters
|
|
111
DELISTED
CIFC LLC Common Shares
CIFC
| $141K | 0.11% |
12,640
-330
| -3% | -$2.95K |
2016 Q1
2 quarters
|
|
112
Element Solutions
ESI
$8.66B
| $134K | 0.1% |
16,500
+5,000
| +43% | +$44.6K |
2015 Q4
3 quarters
|
|
113
Galectin Therapeutics
GALT
$374M
| $134K | 0.1% |
118,200
+58,600
| +98% | +$104K |
2013 Q2
13 quarters
|
|
114
Century Casinos
CNTY
$22.4M
| $121K | 0.09% |
17,500
| – | – |
2015 Q2
5 quarters
|
|
115
INNOVATE Corp
VATE
$84.7M
| $109K | 0.08% |
+2,000
| New | +$92.2K |
2016 Q3
0 quarters
|
|
116
Axogen
AXGN
$2.09B
| $104K | 0.08% |
11,500
-500
| -4% | -$4.07K |
2015 Q2
5 quarters
|
|
117
DELISTED
Fortress Investment Group Llc
FIG
| $99K | 0.07% |
20,000
| – | – |
2016 Q1
2 quarters
|
|
118
Nuwellis
NUWE
$1.76M
| – | – |
0
| – | – |
2013 Q4
11 quarters
|
|
119
BioLineRX
BLRX
$10.2M
| $51K | 0.04% |
73
| – | – |
2014 Q1
10 quarters
|
|
120
XTI Aerospace
XTIA
$30.8M
| – | – |
0
| – | – |
2016 Q1
2 quarters
|
|
121
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
| $18K | 0.01% |
16,000
| – | – |
2015 Q4
3 quarters
|
|
122
Bridgeline Digital
BLIN
$9.09M
| $16K | 0.01% |
80
+40
| +100% | +$8.51K |
2016 Q2
1 quarter
|
|
|
PDL.B
123
DELISTED
PRESIDENTAL RLTY CL B
PDL.B
| $1K | ﹤0.01% |
30,700
| – | – |
2013 Q2
13 quarters
|
|
|
124
Johnson Controls International
JCI
$89.4B
| – | – |
-17,715
| Closed | -$821K | – |
|
125
Kinder Morgan
KMI
$73.1B
| – | – |
-14,081
| Closed | -$264K | – |
|
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q3 2016 Portfolio in Review
As of Q3 2016, Benchmark Capital Advisors held 141 positions worth $132M, up 8% from $123M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Benchmark Capital Advisors's Q3 2016 filing shows 8 new, 35 increased, 44 reduced and 7 closed positions. Its largest new stake was Alibaba: 17,570 shares worth $1.86M. The largest sale was Sarepta Therapeutics, an estimated $1.73M.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 18% a quarter earlier, followed by Real Estate and Healthcare.
- Benchmark Capital Advisors's largest Q3 2016 buy was Alibaba: 17,570 shares worth $1.86M.
- Benchmark Capital Advisors added most to Meta Platforms (Facebook) in Q3 2016, an estimated $1.55M increase.
- Benchmark Capital Advisors's biggest Q3 2016 reduction was Sarepta Therapeutics, cutting an estimated $1.73M.
- Benchmark Capital Advisors fully exited Johnson Controls International in Q3 2016, selling an estimated $821K.
- Benchmark Capital Advisors's ten largest holdings make up 31% of its $132M portfolio in Q3 2016.
- Benchmark Capital Advisors opened 8 new positions and closed 7 in Q3 2016.
- Benchmark Capital Advisors's portfolio value rose 8% quarter-over-quarter to $132M.
Based on Benchmark Capital Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.